PYC ASX - LONG- Biotech technology is ahead of his game within its field
- Successful lab testing
- Has government support with tax rebate given
- Growing the team with world renown specialists
- Strong potential for JV or investment backing
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.095 AUD
−37.73 M AUD
0.00 AUD
146.93 M
About PYC THERAPEUTICS LIMITED
Sector
CEO
Rohan Hockings
Headquarters
Nedlands
Website
Founded
2001
ISIN
AU000000PYC7
FIGI
BBG000BWKBQ1
PYC Therapeutics Ltd. is a drug-development company, which provides a new generation of RNA therapeutics to meet unmet need in disease. It develops intracellular biological therapeutics including its own preclinical oncology payloads, using its proprietary cell Functional Penetrating Phylomers. The company was founded by Richmond Miles Hopkins and Paul Michael Watt on October 9, 2001, and is headquartered in Nedlands, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PYC is 1.370 AUD — it has decreased by −2.86% in the past 24 hours. Watch PYC THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange PYC THERAPEUTICS LIMITED stocks are traded under the ticker PYC.
PYC stock has fallen by −7.80% compared to the previous week, the month change is a −28.42% fall, over the last year PYC THERAPEUTICS LIMITED has showed a 30.48% increase.
We've gathered analysts' opinions on PYC THERAPEUTICS LIMITED future price: according to them, PYC price has a max estimate of 4.80 AUD and a min estimate of 2.40 AUD. Watch PYC chart and read a more detailed PYC THERAPEUTICS LIMITED stock forecast: see what analysts think of PYC THERAPEUTICS LIMITED and suggest that you do with its stocks.
PYC stock is 7.31% volatile and has beta coefficient of 1.57. Track PYC THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is PYC THERAPEUTICS LIMITED there?
Today PYC THERAPEUTICS LIMITED has the market capitalization of 634.59 M, it has decreased by −6.67% over the last week.
Yes, you can track PYC THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
PYC THERAPEUTICS LIMITED is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
PYC earnings for the last half-year are −0.06 AUD per share, whereas the estimation was −0.07 AUD, resulting in a 14.29% surprise. The estimated earnings for the next half-year are −0.04 AUD per share. See more details about PYC THERAPEUTICS LIMITED earnings.
PYC THERAPEUTICS LIMITED revenue for the last half-year amounts to 0.00 AUD, matching the estimated figure, and no changes in revenue are expected for the next half-year.
PYC net income for the last half-year is −22.63 M AUD, while the previous report showed −15.09 M AUD of net income which accounts for −49.92% change. Track more PYC THERAPEUTICS LIMITED financial stats to get the full picture.
No, PYC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PYC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PYC THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PYC THERAPEUTICS LIMITED technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PYC THERAPEUTICS LIMITED stock shows the buy signal. See more of PYC THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.